Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort)
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort)
复制标题
DOI：
10.29262/ram.v64i3.244
复制
发表时间：
2017-09-01
期刊：
影响因子：
--
通讯作者：
Cardona, Ricardo
中科院分区：
文献类型：
--
作者：
Sánchez, Jorge;Toro, Yuliana;Cardona, Ricardo
背景技术背景：现实生活中的影响，指导方针的管理异位性皮炎已经studyed.OBJECTIVE：评估异位性皮炎的临床控制在居民的热带地区管理根据国际consensus.METHODS：前瞻性研究，24个月的后续行动。临床反应进行了评估与SCORAD，DLQI和主观量表（SS）的严重程度知觉patient.RESULTS：233例患者分层根据SCORAD：53轻度严重程度（22%），116中度（49%）和64严重（27%）。基线SCORAD平均值为33（15-41），DLQI为14（11-20），主观量表为85%（67-99）。6个月时，有显著降低（p
BACKGROUND: Real-life impact of guidelines for the management of atopic dermatitis has been poorly studied.OBJECTIVE: To assess atopic dermatitis clinical control in residents of a tropical area managed according to international consensuses.METHODS: Prospective study with a 24-month follow-up. Clinical response was assessed with SCORAD, DLQI and a subjective scale (SS) on severity perception by the patient.RESULTS: Two-hundred and thirty-three patients were stratified according to SCORAD: 53 had mild severity (22%), 116 moderate (49%) and 64 severe (27%). Baseline SCORAD mean was 33 (15-41), for DLQI, it was 14 (11-20), and for the subjective scale, 85% (67-99). At 6 months, there was significant reduction (p